FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225428305> ?p ?o ?g. }

• W4225428305 abstract "Abstract Background Despite calls for the use of additional real-world evidence (RWE) during drug development, rates of inclusion at the regulatory stage remain low. The medicine adoption model suggests that providing additional RWE to regulators would result in a wider indicated population than providing randomised-controlled trial evidence (RCTE) alone. Here, we tested this hypothesis. Methods All engagements concerning the 88 orphan drugs approved between 2009 and 2019 on the European Medicines Agency Orphan Register were reviewed between September and December 2019. Engagements were grouped as containing either randomised-controlled trial evidence (RCTE) or RCTE with real-world evidence (RWE). The data on indicatable population (the therapeutic indication requested by an engagement) and indicated population (the therapeutic indication ultimately granted) as well as the median number of criteria limiting the indicated population in each study type (RCTE/RWE) was extracted. A chi-square test assessed the association between the indicated population (as a proportion of the indicatable population) and type of evidence (RCTE with or without RWE) and a Wilcoxon rank sum test assessed the difference between the median number of limiting criteria between RCTE and RWE studies. Prediction modelling extrapolated the results of a power analysis to a level expected to deliver significance and the time this would take. Results The review identified 103 engagements, of which three were excluded (one contained only RWE; two contained only systematic literature reviews), leaving 100 engagements for 87 orphan medicines in the final analysis. Only 13% of engagements contained RWE. Although the difference was statistically insignificant, 76.92% of engagements containing RCTE and RWE resulted in a broader indicated population as compared to only 56.32% of those that contained RCTE alone. The median number of limiting criteria from RCTE (37 (28, 43)) and RWE (5 (2, 9)) studies varied significantly ( p = 0.005). Modelling suggested that the analysis would achieve sufficient power by 2033–37 at the current RWE adoption rate. Conclusion The proportion of the disease population studied in RWE was greater than that in RCTE. The analysis testing the relationship between additional RWE and broader indicated population would achieve adequate power between 2032 and 2037 at the current RWE adoption rate." @default.
• W4225428305 created "2022-05-05" @default.
• W4225428305 creator A5003624556 @default.
• W4225428305 date "2022-05-04" @default.
• W4225428305 modified "2023-10-18" @default.
• W4225428305 title "The effect of adding real-world evidence to regulatory submissions on the breadth of population indicated for rare disease medicine treatment by the European Medicines Agency" @default.
• W4225428305 cites W2006546370 @default.
• W4225428305 cites W2153434255 @default.
• W4225428305 cites W2528753998 @default.
• W4225428305 cites W2755504031 @default.
• W4225428305 cites W2784620362 @default.
• W4225428305 cites W2888888819 @default.
• W4225428305 cites W2940033607 @default.
• W4225428305 cites W2945294914 @default.
• W4225428305 cites W2995118312 @default.
• W4225428305 cites W3003751458 @default.
• W4225428305 cites W3043843916 @default.
• W4225428305 cites W3091145119 @default.
• W4225428305 cites W3099510265 @default.
• W4225428305 cites W3113799072 @default.
• W4225428305 cites W3161369795 @default.
• W4225428305 cites W3172542805 @default.
• W4225428305 cites W3173305164 @default.
• W4225428305 cites W4255429905 @default.
• W4225428305 cites W4299584209 @default.
• W4225428305 doi "https://doi.org/10.1186/s40545-022-00433-z" @default.
• W4225428305 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35509059" @default.
• W4225428305 hasPublicationYear "2022" @default.
• W4225428305 type Work @default.
• W4225428305 citedByCount "2" @default.
• W4225428305 countsByYear W42254283052023 @default.
• W4225428305 crossrefType "journal-article" @default.
• W4225428305 hasAuthorship W4225428305A5003624556 @default.
• W4225428305 hasBestOaLocation W42254283051 @default.
• W4225428305 hasConcept C104863432 @default.
• W4225428305 hasConcept C108170787 @default.
• W4225428305 hasConcept C111472728 @default.
• W4225428305 hasConcept C126322002 @default.
• W4225428305 hasConcept C127413603 @default.
• W4225428305 hasConcept C12868164 @default.
• W4225428305 hasConcept C138885662 @default.
• W4225428305 hasConcept C142724271 @default.
• W4225428305 hasConcept C168563851 @default.
• W4225428305 hasConcept C188198153 @default.
• W4225428305 hasConcept C204787440 @default.
• W4225428305 hasConcept C206041023 @default.
• W4225428305 hasConcept C2908647359 @default.
• W4225428305 hasConcept C512399662 @default.
• W4225428305 hasConcept C60644358 @default.
• W4225428305 hasConcept C71924100 @default.
• W4225428305 hasConcept C75480439 @default.
• W4225428305 hasConcept C78519656 @default.
• W4225428305 hasConcept C86803240 @default.
• W4225428305 hasConcept C99454951 @default.
• W4225428305 hasConceptScore W4225428305C104863432 @default.
• W4225428305 hasConceptScore W4225428305C108170787 @default.
• W4225428305 hasConceptScore W4225428305C111472728 @default.
• W4225428305 hasConceptScore W4225428305C126322002 @default.
• W4225428305 hasConceptScore W4225428305C127413603 @default.
• W4225428305 hasConceptScore W4225428305C12868164 @default.
• W4225428305 hasConceptScore W4225428305C138885662 @default.
• W4225428305 hasConceptScore W4225428305C142724271 @default.
• W4225428305 hasConceptScore W4225428305C168563851 @default.
• W4225428305 hasConceptScore W4225428305C188198153 @default.
• W4225428305 hasConceptScore W4225428305C204787440 @default.
• W4225428305 hasConceptScore W4225428305C206041023 @default.
• W4225428305 hasConceptScore W4225428305C2908647359 @default.
• W4225428305 hasConceptScore W4225428305C512399662 @default.
• W4225428305 hasConceptScore W4225428305C60644358 @default.
• W4225428305 hasConceptScore W4225428305C71924100 @default.
• W4225428305 hasConceptScore W4225428305C75480439 @default.
• W4225428305 hasConceptScore W4225428305C78519656 @default.
• W4225428305 hasConceptScore W4225428305C86803240 @default.
• W4225428305 hasConceptScore W4225428305C99454951 @default.
• W4225428305 hasIssue "1" @default.
• W4225428305 hasLocation W42254283051 @default.
• W4225428305 hasLocation W42254283052 @default.
• W4225428305 hasLocation W42254283053 @default.
• W4225428305 hasOpenAccess W4225428305 @default.
• W4225428305 hasPrimaryLocation W42254283051 @default.
• W4225428305 hasRelatedWork W150703042 @default.
• W4225428305 hasRelatedWork W2029826733 @default.
• W4225428305 hasRelatedWork W2044698142 @default.
• W4225428305 hasRelatedWork W2410837653 @default.
• W4225428305 hasRelatedWork W2954475304 @default.
• W4225428305 hasRelatedWork W3084077432 @default.
• W4225428305 hasRelatedWork W3159250744 @default.
• W4225428305 hasRelatedWork W4256514411 @default.
• W4225428305 hasRelatedWork W4292236216 @default.
• W4225428305 hasRelatedWork W2083697902 @default.
• W4225428305 hasVolume "15" @default.
• W4225428305 isParatext "false" @default.
• W4225428305 isRetracted "false" @default.
• W4225428305 workType "article" @default.